BRPI0917625B8 - substratos que fornecem liberações múltiplas de agentes ativos - Google Patents

substratos que fornecem liberações múltiplas de agentes ativos Download PDF

Info

Publication number
BRPI0917625B8
BRPI0917625B8 BRPI0917625A BRPI0917625A BRPI0917625B8 BR PI0917625 B8 BRPI0917625 B8 BR PI0917625B8 BR PI0917625 A BRPI0917625 A BR PI0917625A BR PI0917625 A BRPI0917625 A BR PI0917625A BR PI0917625 B8 BRPI0917625 B8 BR PI0917625B8
Authority
BR
Brazil
Prior art keywords
active agents
layer
polymer matrix
substrates
multiple releases
Prior art date
Application number
BRPI0917625A
Other languages
English (en)
Inventor
Jo Smiltneek Andrea
William Koenig David
Robert Hoffman Douglas
Richard Seidling Jeffery
Ann Carney Sara
W Wenzel Scott
Original Assignee
Kimberly Clark Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42240831&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0917625(B8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kimberly Clark Co filed Critical Kimberly Clark Co
Publication of BRPI0917625A2 publication Critical patent/BRPI0917625A2/pt
Publication of BRPI0917625B1 publication Critical patent/BRPI0917625B1/pt
Publication of BRPI0917625B8 publication Critical patent/BRPI0917625B8/pt
Publication of BRPI0917625C1 publication Critical patent/BRPI0917625C1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08—Materials for coatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08—Materials for coatings
    • A61L29/085—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B27/00—Layered products comprising a layer of synthetic resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings
    • A61L2300/608—Coatings having two or more layers
    • A61L2300/61—Coatings having two or more layers containing two or more active agents in different layers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Laminated Bodies (AREA)

Abstract

substratos que fornecem liberações múltiplas de agentes ativos a presente invenção compreende um substrato polimérico que fornece liberações múltiplas de agentes ativos. um substrato é fornecido para entrega em fases múltiplas de agentes ativos, apresentando uma primeira camada de matriz de polímero com um primeiro agente ativo disposto nela, urna segunda camada de matriz de polímero com um segundo agente ativo disposto nela e uma camada de coacervado disposta entre a primeira camada de matriz de polímero e a segunda camada de matriz de polímero. os primeiro e segundo agentes ativos selecionados são incluídos nas primeira e segunda matrizes de polímero, tal que, conforme a primeira e a segunda matrizes de polímero se dissolvam, os agentes ativos sejam liberados. a liberação de agentes ativos em fases múltiplas é conseguida por construção de camadas múltiplas de urna uma matriz de polímero contendo agentes ativos formados com polímeros apresentando diferentes características de solubilidade ou com agentes ativos em diferentes níveis de concentração.
BRPI0917625A 2008-12-16 2009-11-16 substratos que fornecem liberações múltiplas de agentes ativos BRPI0917625C1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/336,243 2008-12-16
US12/336,243 US8551517B2 (en) 2008-12-16 2008-12-16 Substrates providing multiple releases of active agents
PCT/IB2009/055106 WO2010070483A2 (en) 2008-12-16 2009-11-16 Substrates providing multiple releases of active agents

Publications (4)

Publication Number Publication Date
BRPI0917625A2 BRPI0917625A2 (pt) 2015-11-17
BRPI0917625B1 BRPI0917625B1 (pt) 2020-05-12
BRPI0917625B8 true BRPI0917625B8 (pt) 2020-05-26
BRPI0917625C1 BRPI0917625C1 (pt) 2021-05-25

Family

ID=42240831

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0917625A BRPI0917625C1 (pt) 2008-12-16 2009-11-16 substratos que fornecem liberações múltiplas de agentes ativos

Country Status (7)

Country Link
US (1) US8551517B2 (pt)
EP (1) EP2365908B1 (pt)
KR (1) KR101456949B1 (pt)
AU (1) AU2009329223B2 (pt)
BR (1) BRPI0917625C1 (pt)
MX (1) MX2011006330A (pt)
WO (1) WO2010070483A2 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9237972B2 (en) * 2008-12-16 2016-01-19 Kimberly-Clark Worldwide, Inc. Liquid surfactant compositions that adhere to surfaces and solidify and swell in the presence of water and articles using the same
US8480852B2 (en) 2009-11-20 2013-07-09 Kimberly-Clark Worldwide, Inc. Cooling substrates with hydrophilic containment layer and method of making
DK2338535T3 (da) * 2009-12-18 2012-09-24 Dentsply Ih Ab Medicinsk indretning til anvendelse i kort tid med hurtigt frigivende antibakterielt middel
TWI422399B (zh) * 2011-01-21 2014-01-11 Tritech Biopharmaceuticals Co Ltd 促進第五型磷酸二酯酶抑制劑經皮吸收的醫藥組成物
WO2013025572A1 (en) * 2011-08-12 2013-02-21 Rutgers, The State University Of New Jersey An interpolymer network delivery system
US8545951B2 (en) * 2012-02-29 2013-10-01 Kimberly-Clark Worldwide, Inc. Endotracheal tubes and other polymer substrates including an anti-fouling treatment
CN103239754B (zh) * 2013-05-15 2015-03-18 天津开发区金衫包装制品有限公司 应用海藻酸钙纤维的复合医用敷料
WO2014193410A1 (en) 2013-05-31 2014-12-04 Empire Technology Development Llc Method and device for detecting device colonization
WO2014193402A1 (en) * 2013-05-31 2014-12-04 Empire Technology Development Llc Detection of luminal urinary catheter colonization
US9535043B2 (en) 2013-05-31 2017-01-03 Empire Technology Development Llc Color change indicator of biofilm formation
AU2015209243B2 (en) 2014-01-24 2019-01-17 Avent, Inc. Traumatic wound dressing system with conformal cover
JP6554474B2 (ja) 2014-01-24 2019-07-31 アヴェント インコーポレイテッド ラップを含む外傷性創傷ドレッシングシステム
CN108024946A (zh) * 2015-08-04 2018-05-11 尤法玛私人有限公司 润肤剂组合物
WO2020040783A1 (en) 2018-08-24 2020-02-27 Avent, Inc. Polyurethanes as oxygen delivery carriers
WO2020040785A1 (en) 2018-08-24 2020-02-27 Avent, Inc. Formulations for generating oxygen
WO2020040781A1 (en) 2018-08-24 2020-02-27 Avent, Inc. Polymeric hydroperoxides as oxygen delivery agents
KR20210081352A (ko) * 2018-10-24 2021-07-01 솜니오 글로벌 홀딩스, 엘엘씨 기능적 상처 치유 드레싱
CN111012955A (zh) * 2019-11-04 2020-04-17 南京大学 一种改性医用镁合金材料及其制备方法
KR102274661B1 (ko) * 2020-10-26 2021-07-09 주식회사 이노테라피 생체적합성 필름 및 이의 제조방법

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966902A (en) * 1972-05-12 1976-06-29 Airwick Industries, Inc. Polymer complex carriers for an active ingredient
US4500337A (en) * 1980-09-03 1985-02-19 Young Robert W Adherent controlled release microbiocides containing hydrolyzable silanes and organic titanium compounds
US4828912A (en) * 1981-07-20 1989-05-09 Kimberly-Clark Corporation Virucidal product having virucidal and/or germicidal properties
US4897304A (en) * 1981-07-20 1990-01-30 Kimberly-Clark Corporation Virucidal composition, the method of use and the product therefor
US5310559A (en) * 1982-09-01 1994-05-10 Hercon Laboratories Corporation Device for controlled release and delivery to mammalian tissue of pharmacologically active agents incorporating a rate controlling member which comprises an alkylene-alkyl acrylate copolymer
NZ209534A (en) 1983-09-30 1987-01-23 Surgikos Inc Antimicrobial fabric for surgical drape
US4963367A (en) 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
GB8422070D0 (en) * 1984-08-31 1984-10-03 Ici Plc Treated non-woven material
US4643181A (en) * 1986-04-04 1987-02-17 Surgikos, Inc. Antimicrobial dressing or drape material
US4948592A (en) * 1986-05-09 1990-08-14 Alza Corporation Pulsed drug delivery
US4853978A (en) * 1987-07-24 1989-08-08 Surgikos, Inc. Antimicrobial medical glove
US5141803A (en) * 1988-06-29 1992-08-25 Sterling Drug, Inc. Nonwoven wipe impregnating composition
US4837079A (en) * 1988-09-09 1989-06-06 James River Corporation Antimicrobially active, non-woven web used in a wet wiper
DK469989D0 (da) * 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
US5069907A (en) * 1990-03-23 1991-12-03 Phoenix Medical Technology Surgical drape having incorporated therein a broad spectrum antimicrobial agent
US5180585A (en) * 1991-08-09 1993-01-19 E. I. Du Pont De Nemours And Company Antimicrobial compositions, process for preparing the same and use
US5300167A (en) * 1992-01-03 1994-04-05 Kimberly-Clark Method of preparing a nonwoven web having delayed antimicrobial activity
US5567372A (en) * 1993-06-11 1996-10-22 Kimberly-Clark Corporation Method for preparing a nonwoven web containing antimicrobial siloxane quaternary ammonium salts
US5817325A (en) * 1996-10-28 1998-10-06 Biopolymerix, Inc. Contact-killing antimicrobial devices
AU692220B2 (en) * 1993-12-20 1998-06-04 Biopolymerix, Inc. Non-leachable antimicrobial material and articles comprising same
EP0754064B1 (en) * 1994-04-08 2003-05-28 Atrix Laboratories, Inc. An adjunctive polymer system for use with medical device
US6774278B1 (en) * 1995-06-07 2004-08-10 Cook Incorporated Coated implantable medical device
US5609629A (en) * 1995-06-07 1997-03-11 Med Institute, Inc. Coated implantable medical device
US5804538A (en) * 1996-06-20 1998-09-08 The Procter & Gamble Company Perfume delivery systems in liquid personal cleansing compositions
US6530951B1 (en) * 1996-10-24 2003-03-11 Cook Incorporated Silver implantable medical device
US5879697A (en) * 1997-04-30 1999-03-09 Schneider Usa Inc Drug-releasing coatings for medical devices
DE69808790T3 (de) * 1997-09-12 2009-07-16 The Procter & Gamble Co., Cincinnati Hautreinigungs- und konditionierungsartikel für haut und haar
US5906825A (en) * 1997-10-20 1999-05-25 Magellan Companies, Inc. Polymers containing antimicrobial agents and methods for making and using same
US6197322B1 (en) * 1997-12-23 2001-03-06 Kimberly-Clark Worldwide, Inc. Antimicrobial structures
WO1999040791A1 (en) * 1998-02-12 1999-08-19 Surfacine Development Company, Llc Disinfectant compositions providing sustained biocidal action
US6206914B1 (en) * 1998-04-30 2001-03-27 Medtronic, Inc. Implantable system with drug-eluting cells for on-demand local drug delivery
JP2002518351A (ja) * 1998-06-19 2002-06-25 オキシバイオ・インコーポレイテッド 抗感染および避妊特性を有する医療装置
US6299604B1 (en) * 1998-08-20 2001-10-09 Cook Incorporated Coated implantable medical device
US6168800B1 (en) * 1998-08-20 2001-01-02 Medwrap Corporation Antimcrobial multi-layer island dressing
HU230454B1 (hu) * 1998-11-02 2016-07-28 Alkermes Pharma Ireland Limited Metilfenidátot tartalmazó módosított felszabadulású sokszemcsés készítmény
US20050033251A1 (en) * 1998-12-08 2005-02-10 Quick-Med Technologies, Inc. Controlled release of biologically active substances from select substrates
US7115535B1 (en) * 1999-08-02 2006-10-03 The Procter & Gamble Company Personal care articles comprising batting
FR2797381B1 (fr) * 1999-08-09 2001-11-02 Rhodia Chimie Sa Utilisation d'un polymere hydrosoluble dans une composition biocide pour le traitement des surfaces dures
US20020006886A1 (en) * 1999-11-19 2002-01-17 Peter William Beerse Personal care articles comprising cationic polymer coacervate compositions
US6586000B2 (en) * 1999-12-16 2003-07-01 Dermatrends, Inc. Hydroxide-releasing agents as skin permeation enhancers
AU775841B2 (en) * 1999-12-28 2004-08-19 Kimberly-Clark Worldwide, Inc. A wiper containing a controlled-release anti-microbial agent
ES2195979T3 (es) * 2000-01-13 2003-12-16 Kureha Chemical Ind Co Ltd Microcapsulas de nucleo particulado con una capa de revestimiento laminar estable y procedimiento para su preparacion.
JP2002065879A (ja) 2000-08-25 2002-03-05 Shinatsupusu:Kk マスク
AU2002239436B2 (en) * 2000-10-31 2007-04-26 Cook Medical Technologies Llc Coated implantable medical device
US6767508B1 (en) * 2000-11-28 2004-07-27 Kimberly-Clark Worldwide, Inc. Nonwovens modified with alkyl polyglycoside surfactants
AU2002303438B2 (en) * 2001-04-23 2007-10-25 Smith & Nephew (Overseas) Limited Therapeutic treatments using the direct application of antimicrobial metal compositions
US6592885B2 (en) * 2001-06-07 2003-07-15 Matthew D. Phaneuf Method for making infection-resistant fabricated textile articles for biomedical applications
DE10145529A1 (de) * 2001-09-14 2003-04-03 Creavis Tech & Innovation Gmbh Biozide Retardierungsformulierungen
US6712121B2 (en) * 2001-10-12 2004-03-30 Kimberly-Clark Worldwide, Inc. Antimicrobially-treated fabrics
US7357949B2 (en) * 2001-12-21 2008-04-15 Agion Technologies Inc. Encapsulated inorganic antimicrobial additive for controlled release
US20030118658A1 (en) * 2001-12-21 2003-06-26 Trogolo Jeffrey A. High aspect ratio encapsulated inorganic antimicrobial additive for controlled release
US6835865B2 (en) * 2001-12-21 2004-12-28 Kimberly-Clark Worldwide, Inc. Antimicrobial nonwoven webs for personal care absorbent articles
US6887270B2 (en) * 2002-02-08 2005-05-03 Boston Scientific Scimed, Inc. Implantable or insertable medical device resistant to microbial growth and biofilm formation
US8100872B2 (en) * 2002-10-23 2012-01-24 Tyco Healthcare Group Lp Medical dressing containing antimicrobial agent
JP2004149000A (ja) * 2002-10-30 2004-05-27 Showa Corp 船舶用ガスシリンダ装置
US20050067726A1 (en) 2002-11-04 2005-03-31 Nianxi Yan Microcapsules having multiple shells and method for the preparation thereof
US7264859B2 (en) * 2002-12-19 2007-09-04 Kimberly-Clark Worldwide, Inc. Lubricious coating for medical devices
US7220491B2 (en) * 2002-12-19 2007-05-22 Kimberly-Clark Worldwide, Inc. Lubricious coating for medical devices
GB2397523A (en) 2003-01-22 2004-07-28 Avecia Ltd Biocide composition for cellulosic materials
US20040151919A1 (en) * 2003-01-31 2004-08-05 Kimberly-Clark Worldwide, Inc. Glove having reduced microbe affinity and transmission
SE0400073D0 (sv) 2003-04-04 2004-01-14 Appear Sweden Hb Antibacterial material
DE10328261B4 (de) * 2003-06-23 2007-10-25 Beiersdorf Ag Desinfizierende Auflage mit Silberbeschichtung und ihre Verwendung
US20060210600A1 (en) * 2003-07-07 2006-09-21 Medtronic Vascular, Inc. Coated stent with timed release of multiple therapeutic agents to inhibit restenosis adjacent to the stent ends
EP1518568B1 (en) * 2003-09-25 2009-05-27 Wageningen Universiteit, Agrotechnologie en Voedingswetenschappen Complex coacervate core micelles as anti-fouling agents
US20060147502A1 (en) * 2004-12-30 2006-07-06 Kimberly-Clark Worldwide, Inc. Methods for controlling microbial pathogens on currency and mail
US7845351B2 (en) * 2005-08-31 2010-12-07 Kimberly-Clark Worldwide Inc. Germicidal face mask
US20070048358A1 (en) * 2005-08-31 2007-03-01 Schorr Phillip A Antimicrobial substrates
US20070298067A1 (en) * 2006-06-22 2007-12-27 Boston Scientific Scimed, Inc. Control release drug coating for medical devices
US20070298069A1 (en) * 2006-06-26 2007-12-27 Boston Scientific Scimed, Inc. Medical devices for release of low solubility therapeutic agents

Also Published As

Publication number Publication date
KR20110110117A (ko) 2011-10-06
BRPI0917625C1 (pt) 2021-05-25
WO2010070483A3 (en) 2010-09-02
BRPI0917625A2 (pt) 2015-11-17
EP2365908B1 (en) 2016-11-02
WO2010070483A2 (en) 2010-06-24
AU2009329223A1 (en) 2010-06-24
KR101456949B1 (ko) 2014-10-31
BRPI0917625B1 (pt) 2020-05-12
MX2011006330A (es) 2011-06-27
EP2365908A4 (en) 2013-04-17
AU2009329223B2 (en) 2014-09-18
EP2365908A2 (en) 2011-09-21
US20100150989A1 (en) 2010-06-17
US8551517B2 (en) 2013-10-08

Similar Documents

Publication Publication Date Title
BRPI0917625B8 (pt) substratos que fornecem liberações múltiplas de agentes ativos
CR20110186A (es) Formulación farmacéutica 514
BRPI0920453A2 (pt) pelicula de seda, construção para engenharia de tecido, metodos para preparar uma película de seda, para cobrir uma superfície de um substrato com uma composição de seda, e para embutir pelo menos um agente ativo em uma película de seda, e, substrato coberto com película de sedal
BR112014004460A2 (pt) material polimérico para um recipiente isolado
CR11681A (es) Compuestos heterociclicos novedosos y usos de los mismos
PE20090670A1 (es) Material compuesto polimerico con funcionalidad biocida
PE20091574A1 (es) Sistema de administracion de drogas con efecto estabilizante
GB2483815A (en) Composition comprising oil drops
BR112014026037A2 (pt) sistemas de peridrolase em formato de dose unitária
CL2009000393A1 (es) Composición farmaceutica que comprende a) un agente farmaceutico activable, b) un agente activo plasmonico; util para el tratamiento de trastornos de proliferación celular.
BR112015012670A2 (pt) composições de liberação controlada e métodos de uso
ES2570607T3 (es) Película revestida con un fluoropolímero, procedimiento para formar la misma, y composición líquida de fluoropolímero
ES2570160T3 (es) Composición de revestimiento de liberación, material de base y procedimiento de producción de un material de base, y agente de tratamiento de superficie para un material de base y utilización de un agente de tratamiento de superficie
WO2012149494A3 (en) Coating compositions, methods and coated devices
BR112018003586A2 (pt) dispositivo atuador e/ou sensor
CR20140487A (es) Peliculas de capas multiples capaces de liberar ingredientes activos por un periodo limitado de tiempo
BRPI0705960A2 (pt) composiÇÕes polimÉricas compreendendo pelo menos um polÍmero de exclusço de volume
UY35859A (es) ?combinación farmacéutica que comprende amlodipina, losartán y rosuvastatina?.
WO2014059269A3 (en) Multilayer compositions, coated devices and use thereof
AR072685A1 (es) Composicion topica para el tratamiento de queratosis actinica
CL2014000636A1 (es) Composicion detergente enzimatica que comprende la combinacion de un sistema tensioactivo, una o mas enzimas y uno o mas compuestos de lignina; y procedimiento para el tratamiento de un sustrato.
BR112015000494A2 (pt) matriz e composições da camada para a proteção dos biotivos
CR20120133A (es) Composiciën de entrega de agente activo atrapado en carbohidrato y articulos que usan el mismo
CO6561814A2 (es) Tira dental para la administracion de tratamiento por la via oral
BR112014021068A2 (pt) Inibidor de uma interação entre fosfatidilserina e um receptor tim, composição farmacêutica e uso de um inibidor

Legal Events

Date Code Title Description
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 12/05/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REF. RPI 2575 DE 12/05/2020 QUANTO AO TITULAR E AOS INVENTORES.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 16/11/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF